# Chemotherapy for Patients With Non-Small Cell Lung Cancer

> **NCT00380718** · PHASE4 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 33 (actual)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **DRUG:** pemetrexed

## Key facts

- **NCT ID:** NCT00380718
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2008-09
- **Final completion:** 2009-11
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2010-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00380718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00380718, "Chemotherapy for Patients With Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00380718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*